Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGEN CORP Regulatory Filings 2017

Oct 6, 2017

32081_rns_2017-10-06_86cecf87-506f-4087-9b46-3bd7725c5935.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-K 1 d453103d8k.htm 8-K 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 5, 2017

NEOGEN CORPORATION

(Exact name of registrant as specified in its charter)

MICHIGAN 0-17988 38-2367843
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
620 Lesher Place Lansing, Michigan 48912
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code 517-372-9200

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders

On October 5, 2017, Neogen Corporation (the “Company”) held its 2017 Annual Meeting of Shareholders. At the meeting 35,991,670 of the 38,201,867 shares outstanding and entitled to vote were present and voted. The matters listed below were submitted to a vote of the shareholders though the solicitation of proxies. The proposals are described in detail in the Company’s Proxy Statement dated as of, and filed with Securities and Exchange Commission on, August 30, 2017. The voting results are as follows:

Proposal 1 – Election of Directors

Nominee For Withheld
James L. Herbert 30,835,245 1,228,400
G. Bruce Papesh 30,368,613 1,695,032
Thomas H. Reed 31,577,008 486,637
Darci L. Vetter 30,849,557 1,214,088

Proposal 2 – To Approve, by Non-Binding Vote, the Compensation of Executives

The shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy materials.

For Against Abstain Broker Non-Vote
31,782,719 164,454 116,189 3,928,308

Proposal 3 – Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm

The shareholders ratified the appointment of BDO USA LLP as the Company’s auditors for the fiscal year ending May 31, 2018.

For Against Abstain Broker Non-Vote
35,772,822 162,620 56,227 0

Proposal 4 – To Approve, by Non-Binding Vote, the Frequency of Future Shareholder Advisory votes on Executive Compensation

The shareholders approved, on an advisory basis, the Board’s recommendation to hold the shareholder advisory vote on executive compensation annually.

Annual Every 2 Years Every 3 Years Abstain Broker Non-Vote
26,823,783 98,103 5,073,222 68,536 3,928,026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

(Registrant)
Date: October 6, 2017
/s/ Steven J. Quinlan
Steven J. Quinlan
Vice President & CFO